Drugmakers, PhRMA seek to join hospitals’ 340B rebate lawsuit

AbbVie, Bristol Myers Squibb, Boehringer Ingelheim and PhRMA are asking to intervene in the hospital industry’s lawsuit seeking to block HRSA’s revised 340B Rebate Model Pilot Program, according to court filings in the U.S. District Court for the District of Maine. AbbVie and its Pharmacyclics unit, Bristol Myers Squibb and Boehringer Ingelheim filed a motion […] The post Drugmakers, PhRMA seek to join hospitals’ 340B rebate lawsuit appeared first on Becker's Hospita...